"Integrity, Ethics and risk management are boardroom matters which are directly impacted by AI", said Jesus Mantas, Senior Managing Partner at IBM and board member at Biogen Inc. "Board directors have a duty to provide oversight to the enhancements required to integrity principles, 'human in the loop' policies, and risk management frameworks to include the effect of AI algorithms becoming the norm in every operational aspect of corporations."

There’s no question that companies need to get a better handle on data...“But that is not sufficient unless each one of your stakeholders actually trusts the data you’re providing and what you’re doing with it,” says IBM Managing Partner Jesus Mantas.

Biogen today announced the nomination of John R. Chiminski, William A. Hawkins and Jesus B. Mantas to stand for election to the company’s board of directors at its 2019 annual meeting of stockholders, scheduled for June 19, 2019. “We are excited to announce the nomination of John, Bill and Jesus for election to Biogen’s Board. Their diverse backgrounds and experience in scientific, medical, and digital innovation are highly complementary to our pioneering vision,” said Michel Vounatsos, Biogen’s Chief Executive Officer.

"A key to success [in the new era of AI] is to focus on the design of the human-AI interactions as much as in the AI itself," said Jesus Mantas, general manager and managing partner in IBM Global Business Services. “Many AI programs focus primarily on machine learning algorithms and training datasets, but fail to address the most important success factors...